Rates of routine cancer screening and diagnosis before vs after the COVID-19 pandemic

AH Oakes, K Boyce, C Patton, S Jain - JAMA oncology, 2023 - jamanetwork.com
Methods| This cross-sectional study used the Trilliant Health all-payer claims and
encounters database, which includes inpatient, outpatient, and prescription drug claims from …
被引用次数：35 相关文章
[HTML] nih.gov

[HTML][HTML] Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic

AH Oakes, K Boyce, C Patton, S Jain - JAMA Oncology, 2023 - ncbi.nlm.nih.gov
Methods This cross-sectional study used the Trilliant Health all-payer claims and encounters
database, which includes inpatient, outpatient, and prescription drug claims from all 50 …

[引用][C] Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic

AH Oakes, K Boyce, C Patton, S Jain - JAMA oncology, 2023 - pubmed.ncbi.nlm.nih.gov
Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic
Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic …

Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic.

AH Oakes, K Boyce, C Patton, S Jain - JAMA Oncology, 2023 - europepmc.org
Methods This cross-sectional study used the Trilliant Health all-payer claims and encounters
database, which includes inpatient, outpatient, and prescription drug claims from all 50 …

[引用][C] Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic.

AH Oakes, K Boyce, C Patton, S Jain - JAMA Oncology, 2022 - europepmc.org
Rates of Routine Cancer Screening and Diagnosis Before vs After the COVID-19 Pandemic. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …